Sharps Technology Issues Treasury Update, Highlights Solana Strategy And Coinbase Validator Partnership; Reports 7% APY On Staked SOL, Maintains Debt-Free Balance Sheet

Sharps Technology, Inc. ("STSS" or the "Company"), a medical device company implementing a Solana-based digital asset treasury strategy, today issued an update on its treasury and recent operational highlights.

Treasury Updates

• Staking: Since inception, STSS's validator partners have generated ~7% gross annual percentage yield (APY) before fees, outperforming the Solana network average. Nearly all of the Company's SOL holdings are currently staked.
• Balance Sheet: STSS continues to maintain sufficient operating capital and has no corporate debt.

Recent Operational Highlights

• In January, STSS announced a lock-up agreement with its Strategic Advisor to restrict sales of its advisory warrants and any underlying shares. The Strategic Advisor has also confirmed none of its advisory warrants and underlying shares have been sold or hedged prior to this agreement.
• In January, STSS launched a jointly supported institutional-grade Solana validator in partnership with Coinbase, to which STSS has delegated a portion of its SOL treasury holdings.